Y K Hamied buys 5.22% additional stake in Cipla

03 Feb 2016 Evaluate

In a move aimed at realignment of family shareholding, Cipla patriarch Y K Hamied, Non-Executive Chairman of the company has acquired 5.22% additional stake in the company from his wife Farida Hamied. Following the acquisition, his total holding in the drug firm increased to 20.76% from earlier stake of 15.54%.

The transfer of shares is being done by way of gift. The development comes at a time when the Mumbai-based drug maker is in the midst of a transition in leadership.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 150 countries. Its portfolio includes 1500 plus products across therapeutic categories with one quality standard globally.

Cipla Share Price

1489.15 -1.55 (-0.10%)
10-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.25
Dr. Reddys Lab 1251.10
Cipla 1489.15
Zydus Lifesciences 923.70
Lupin 2055.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×